Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2 Interventional

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

ClinicalTrials.gov ID: NCT05904080

Public ClinicalTrials.gov record NCT05904080. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase 2 Study of Nivolumab and Ipilimumab With or Without Cabozantinib in Patients With Advanced Nasopharyngeal Carcinoma That Have Progressed After Platinum Treatment and Immunotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to other places in the body (metastatic), or for which no treatment is currently available (incurable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving immunotherapy with nivolumab and ipilimumab and targeted therapy with cabozantinib may help shrink and stabilize nasopharyngeal cancer.

Study identification

NCT ID
NCT05904080
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2
Enrollment
50 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2024 (Actual)
Primary completion
Jun 16, 2028 (Estimated)
Completion
Jun 16, 2028 (Estimated)
Last update posted
Sep 21, 2026

2024 – 2028

United States locations

U.S. sites
92
U.S. states
23
U.S. cities
75
Facility City State ZIP Site status
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612 —
Keck Medicine of USC Koreatown Los Angeles California 90020 —
Los Angeles General Medical Center Los Angeles California 90033 —
USC / Norris Comprehensive Cancer Center Los Angeles California 90033 —
USC Norris Oncology/Hematology-Newport Beach Newport Beach California 92663 —
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 —
Stanford Cancer Institute Palo Alto Palo Alto California 94304 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706 —
Saint Alphonsus Cancer Care Center-Caldwell Caldwell Idaho 83605 —
Kootenai Health - Coeur d'Alene Coeur d'Alene Idaho 83814 —
Saint Alphonsus Cancer Care Center-Nampa Nampa Idaho 83687 —
Kootenai Clinic Cancer Services - Post Falls Post Falls Idaho 83854 —
Kootenai Clinic Cancer Services - Sandpoint Sandpoint Idaho 83864 —
Northwestern University Chicago Illinois 60611 —
University of Illinois Chicago Illinois 60612 —
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 —
Carle at The Riverfront Danville Illinois 61832 —
Northwestern Medicine Cancer Center Kishwaukee DeKalb Illinois 60115 —
Carle Physician Group-Effingham Effingham Illinois 62401 —
NorthShore University HealthSystem-Evanston Hospital Evanston Illinois 60201 —
Northwestern Medicine Cancer Center Delnor Geneva Illinois 60134 —
NorthShore University HealthSystem-Glenbrook Hospital Glenview Illinois 60026 —
Northwestern Medicine Glenview Outpatient Center Glenview Illinois 60026 —
Northwestern Medicine Grayslake Outpatient Center Grayslake Illinois 60030 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
NorthShore University HealthSystem-Highland Park Hospital Highland Park Illinois 60035 —
Northwestern Medicine Lake Forest Hospital Lake Forest Illinois 60045 —
Carle Physician Group-Mattoon/Charleston Mattoon Illinois 61938 —
UC Comprehensive Cancer Center at Silver Cross New Lenox Illinois 60451 —
Northwestern Medicine Orland Park Orland Park Illinois 60462 —
University of Chicago Medicine-Orland Park Orland Park Illinois 60462 —
Carle Cancer Center Urbana Illinois 61801 —
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555 —
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny Iowa 50023 —
Mercy Cancer Center-West Lakes Clive Iowa 50325 —
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive Iowa 50325 —
Heartland Oncology and Hematology LLP Council Bluffs Iowa 51503 —
Methodist Jennie Edmundson Hospital Council Bluffs Iowa 51503 —
Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ Council Bluffs Iowa 51503 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines Iowa 50309 —
Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines Iowa 50314 —
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee Iowa 50263 —
Tufts Medical Center Boston Massachusetts 02111 —
Sanford Joe Lueken Cancer Center Bemidji Minnesota 56601 —
Mercy Hospital South St Louis Missouri 63128 —
Community Hospital of Anaconda Anaconda Montana 59711 —
Billings Clinic Cancer Center Billings Montana 59101 —
Bozeman Health Deaconess Hospital Bozeman Montana 59715 —
Benefis Sletten Cancer Institute Great Falls Montana 59405 —
Logan Health Medical Center Kalispell Montana 59901 —
Community Medical Center Missoula Montana 59804 —
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC Omaha Nebraska 68114 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Oncology Associates PC Omaha Nebraska 68114 —
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 —
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 —
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 —
Memorial Sloan Kettering Commack Commack New York 11725 —
Memorial Sloan Kettering Westchester Harrison New York 10604 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Memorial Sloan Kettering Nassau Uniondale New York 11553 —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Novant Health Presbyterian Medical Center Charlotte North Carolina 28204 —
Novant Health Cancer Institute - Huntersville Huntersville North Carolina 28078 —
Novant Health Cancer Institute - Matthews Matthews North Carolina 28105 —
Novant Health Cancer Institute - Mooresville Mooresville North Carolina 28117 —
Sanford Bismarck Medical Center Bismarck North Dakota 58501 —
Sanford Broadway Medical Center Fargo North Dakota 58122 —
Sanford Roger Maris Cancer Center Fargo North Dakota 58122 —
Good Samaritan Hospital - Cincinnati Cincinnati Ohio 45220 —
Cancer Centers of Southwest Oklahoma Research Lawton Oklahoma 73505 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146 —
Saint Alphonsus Cancer Care Center-Ontario Ontario Oregon 97914 —
Oregon Health and Science University Portland Oregon 97239 —
Medical University of South Carolina Charleston South Carolina 29425 —
Sanford Cancer Center Oncology Clinic Sioux Falls South Dakota 57104 —
Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota 57117-5134 —
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 —
VCU Massey Cancer Center at Stony Point Richmond Virginia 23235 —
VCU Massey Comprehensive Cancer Center Richmond Virginia 23298 —
West Virginia University Healthcare Morgantown West Virginia 26506 —
Camden Clark Medical Center Parkersburg West Virginia 26101 —
Marshfield Medical Center-EC Cancer Center Eau Claire Wisconsin 54701 —
Marshfield Medical Center-Marshfield Marshfield Wisconsin 54449 —
Marshfield Medical Center - Minocqua Minocqua Wisconsin 54548 —
Marshfield Medical Center-Rice Lake Rice Lake Wisconsin 54868 —
Marshfield Medical Center-River Region at Stevens Point Stevens Point Wisconsin 54482 —
Marshfield Medical Center - Weston Weston Wisconsin 54476 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05904080, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05904080 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →